Home Endocrine complications following pediatric bone marrow transplantation
Article
Licensed
Unlicensed Requires Authentication

Endocrine complications following pediatric bone marrow transplantation

  • Josephine Ho EMAIL logo , Victor Lewis , Gregory M.T. Guilcher , David K. Stephure and Danièle Pacaud
Published/Copyright: May 24, 2011
Journal of Pediatric Endocrinology and Metabolism
From the journal Volume 24 Issue 5-6

Abstract

Pediatric bone marrow transplantation (BMT) for various diseases can lead to endocrine system dysfunction owing to preparative regimens involving chemotherapy and radiation therapy. We assessed the prevalence of post-BMT endocrine complications in children treated at the Alberta Children’s Hospital (ACH) from 1991 to 2001. Time of onset of endocrine dysfunction, underlying disease processes, chemotherapy, radiation therapy and age at BMT were characterized. Subjects of <18 years of age at the time of allogeneic or autologous BMT for whom 1-year follow-up through the ACH and a chart were available for review were included in the study. Subjects with a pre-existing endocrine condition were excluded. Of the 194 pediatric BMT procedures performed at the ACH between January 1, 1991 and December 31, 2001, 150 complete charts were available for review. Sixty five subjects received follow-up care at other centers and were excluded. Therefore, a total of 85 subjects were included in the review. The prevalence of endocrine complications identified was: primary hypothyroidism 1.2%, compensated hypothyroidism 7.0%, hyperthyroidism 2.4%, hypergonadotrophic hypogonadism 22.4%, abnormal bone density 2.4%, and secondary diabetes mellitus 1.2%. These findings emphasize the need to screen for endocrine system dysfunction, particularly hypergonadotrophic hypogonadism, in children who have undergone BMT. Children need long-term follow-up so that endocrine complications can be diagnosed and treated promptly.


Corresponding author: Dr. Josephine Ho, Division of Pediatric Endocrinology, Alberta Children’s Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta T3B 6A8, Canada Phone: +1 403-9557819, Fax: +1 403-9555001

Published Online: 2011-05-24
Published in Print: 2011-06-01

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Publisher's Note
  2. Publisher's Note
  3. Editorial
  4. The damage caused by incomplete and uncontrolled medical information
  5. Images in Pediatric Endocrinology
  6. Dorsolumbar kyphosis: diagnostic value of hook shaped vertebra
  7. Original Contributions
  8. Are adolescent weight-related problems and general well-being essentially an issue of age, gender or rather a pubertal timing issue?
  9. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves’ disease: efficacy and adverse reactions during initial treatment and long-term outcome
  10. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia
  11. Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens
  12. Stanozolol regulates proliferation of growth plate chondrocytes via activation of ERα in GnRHa-treated adolescent rats
  13. A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy
  14. The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children
  15. A new heterozygous mutation (D196N) in the Gs alpha gene as a cause for pseudohypoparathyroidism type IA in a boy who had gallstones
  16. Causes and patterns of referral to a tertiary, multidisciplinary program for the treatment of childhood obesity
  17. Vitamin D receptor genotypes are associated with bone mass in patients with Turner syndrome
  18. Plasma leptin and adiponectin concentrations in healthy, non-obese children
  19. Puberty and pubertal growth dynamics in children with idiopathic short stature
  20. Endocrine complications following pediatric bone marrow transplantation
  21. Rare hypertension as a result of 17α-hydroxylase deficiency
  22. Girls with early puberty attain a near-final height similar to their target height
  23. Persistent hyperthyrotropinemia in congenital hypothyroidism: successful combination treatment with levothyroxine and liothyronine
  24. Benign transient hyperphosphatasemia in infants and children: a prospective cohort
  25. The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults
  26. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
  27. Glargine basal-bolus insulin regimen versus insulin pump therapy: comparison of glycemic control
  28. Patient Report Letters
  29. A new variant of a known mutation in two siblings with permanent neonatal diabetes mellitus
  30. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes
  31. A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene
  32. Hyperthyroidism presenting with hyperglycemia in an adolescent female
  33. Short Communications
  34. A single base-pair deletion in the WFS1 gene causes Wolfram syndrome
  35. Growth suppression caused by corticosteroid eye drops
  36. Familial glucocorticoid deficiency due to compound heterozygosity of two novel MC2R mutations
  37. Letter to the Editor
  38. Meetings
  39. Meetings Calendar
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem.2011.021/html
Scroll to top button